Actavis Generics is a global pharmaceutical company focused on developing,
manufacturing ... In 1993, Actavis, then Watson, announced its initial public
offering (IPO) of shares of common stock. ......
Oct 31, 2012 ... Actavis (NYSE: ACT) is a global, integrated specialty pharmaceutical company
focused on developing, manufacturing and distributing generic, ...
May 13, 2016 ... MERCK & CIE v. WATSON LABORATORIES INC. 3 considered by the parties
was a joint venture to market and distribute MTHF. J.A. 1287–90 ...
Watson Pharmaceuticals, Inc. (NYSE-WPI) is a global specialty pharmaceutical
company with approximately $3 billion in revenues, a broad product line and ...
The latest litigation news involving the company Watson Pharmaceuticals Inc. (
May 16, 2016 ... ... in Merck & Cie v. Watson Laboratories, Inc., ANDA litigation over claim 4 of
U.S. Patent No. 6441168, which reads: A crystalline calcium salt ...
Oct 15, 2012 ... The Federal Trade Commission will require Watson Pharmaceuticals, Inc. and
Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz ...
77 Watson Pharmaceuticals reviews. A free inside look at company reviews ...
2008–2016, Glassdoor. Glassdoor ® is a registered trademark of Glassdoor, Inc.
Jan 25, 2013 ... Watson Pharmaceuticals is no more. The generic drug company has officially
taken the name of its most recent acquisition target, Actavis ...
May 13, 2016 ... Watson Laboratories, Inc., Nos. 15-2063, -2064 (Fed. Cir. May 13, 2016), the
Federal Circuit found Merck's patent invalid under the on-sale bar ...